Literature DB >> 25982257

Latent Pathways Identification by Microarray Expression Profiles in Thyroid-Associated Ophthalmopathy Patients.

Pingqian Zhao1, Haitao Yin, Chen Tao, Ping Chen, Ying Song, Wenlei Yang, Lin Liu.   

Abstract

This study aimed to screen potential genes related to thyroid-associated ophthalmopathy (TAO) and get a further understanding about the pathogenesis of this disease. GSE9340 was downloaded from Gene Expression Omnibus, including eight thyroid tissue samples from hyperthyroid patients without TAO and ten ones from hyperthyroid patients with TAO. The differentially expressed genes (DEGs) were identified by the linear models for microarray data package. And their potential functions were predicted by Gene Ontology (GO) and pathway enrichment analyses. Furthermore, protein-protein interaction (PPI) was obtained from the Search Tool for the Retrieval of Interacting Genes database, and the PPI network was visualized with Cytoscape. Then, module analysis was performed by the Molecular Complex Detection analysis. Additionally, the potential pathway interactions were identified by Latent Pathway Identification Analysis. Totally, 511 upregulated and 507 downregulated DEGs in TAO were screened. Some DEGs (e.g., UBE2C) were related to cell cycle, and DEGs encoding proteasome (e.g., PSMA1, PSMC5, PSMC4, and PSMD1) were related to negative regulation of ubiquitin-protein ligase activity. Several upregulated DEGs encoding signal recognition particle (e.g., SRP14, SRP54, and SRP9) were found to be enriched in protein export pathway. Furthermore, some pathways (e.g., ribosome and protein export) had interactions. The DEGs related to cell cycle (e.g., UBE2C), DEGs encoding proteasome (e.g., PSMA1, PSMC5, PSMC4, and PSMD1) and signal recognition particle (e.g., SRP14, SRP54, and SRP9), as well as pathways of ribosome, protein export and retinol metabolism, might play key roles in the development of TAO.

Entities:  

Mesh:

Year:  2015        PMID: 25982257     DOI: 10.1007/s12022-015-9373-8

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  22 in total

Review 1.  Graves' disease.

Authors:  A P Weetman
Journal:  N Engl J Med       Date:  2000-10-26       Impact factor: 91.245

2.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

3.  Network-based prediction for sources of transcriptional dysregulation using latent pathway identification analysis.

Authors:  Lisa Pham; Lisa Christadore; Scott Schaus; Eric D Kolaczyk
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

4.  Can autoimmunity against calsequestrin explain the eye and eyelid muscle inflammation of thyroid eye disease?

Authors:  Bamini Gopinath; Leon Wescombe; Bao Nguyen; Jack R Wall
Journal:  Orbit       Date:  2009

5.  APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction.

Authors:  Lixin Wan; Mingjia Tan; Jie Yang; Hiroyuki Inuzuka; Xiangpeng Dai; Tao Wu; Jia Liu; Shavali Shaik; Guoan Chen; Jing Deng; Marcos Malumbres; Anthony Letai; Marc W Kirschner; Yi Sun; Wenyi Wei
Journal:  Dev Cell       Date:  2014-05-27       Impact factor: 12.270

6.  Pirfenidone attenuates the IL-1β-induced hyaluronic acid increase in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.

Authors:  Seung Ah Chung; Bo Kyung Jeon; Youn-Hee Choi; Keum Ok Back; Jong Bok Lee; Koung Hoon Kook
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-09       Impact factor: 4.799

7.  An automated method for finding molecular complexes in large protein interaction networks.

Authors:  Gary D Bader; Christopher W V Hogue
Journal:  BMC Bioinformatics       Date:  2003-01-13       Impact factor: 3.169

8.  The cardiac calsequestrin gene (CASQ2) is up-regulated in the thyroid in patients with Graves' ophthalmopathy--support for a role of autoimmunity against calsequestrin as the triggering event.

Authors:  Leon Wescombe; Hooshang Lahooti; Bamini Gopinath; Jack R Wall
Journal:  Clin Endocrinol (Oxf)       Date:  2010-10       Impact factor: 3.478

9.  Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma.

Authors:  Ilhem Diboun; Lorenz Wernisch; Christine Anne Orengo; Martin Koltzenburg
Journal:  BMC Genomics       Date:  2006-10-09       Impact factor: 3.969

Review 10.  Rituximab for thyroid-associated ophthalmopathy.

Authors:  Neda Minakaran; Daniel G Ezra
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31
View more
  4 in total

1.  Proteomics of Tear in Inactive Thyroid-Associated Ophthalmopathy.

Authors:  L Jiang; R Wei; J Diao; H Ding; W Wang; R Ao
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Jul-Sep       Impact factor: 0.877

2.  Differential expression and alternative splicing of transcripts in orbital adipose/connective tissue of thyroid-associated ophthalmopathy.

Authors:  Lianqun Wu; Yu Liang; Nan Song; Xiying Wang; Chao Jiang; Xinxin Chen; Bing Qin; Xiantao Sun; Guohua Liu; Chen Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2021-06-02

3.  Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model.

Authors:  J Teister; F Anders; S Beck; S Funke; H von Pein; V Prokosch; N Pfeiffer; F Grus
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

4.  Comprehensive analysis of key genes and pathways for biological and clinical implications in thyroid-associated ophthalmopathy.

Authors:  Yueyue Wang; Yanfei Shao; Haitao Zhang; Jun Wang; Peng Zhang; Weizhong Zhang; Huanhuan Chen
Journal:  BMC Genomics       Date:  2022-09-02       Impact factor: 4.547

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.